391 related articles for article (PubMed ID: 8906420)
1. Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: implications for fibroblast function.
Iruela-Arispe ML; Vernon RB; Wu H; Jaenisch R; Sage EH
Dev Dyn; 1996 Oct; 207(2):171-83. PubMed ID: 8906420
[TBL] [Abstract][Full Text] [Related]
2. Enhanced angiogenesis characteristic of SPARC-null mice disappears with age.
Reed MJ; Bradshaw AD; Shaw M; Sadoun E; Han N; Ferara N; Funk S; Puolakkainen P; Sage EH
J Cell Physiol; 2005 Sep; 204(3):800-7. PubMed ID: 15795937
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors.
Reed MJ; Vernon RB; Abrass IB; Sage EH
J Cell Physiol; 1994 Jan; 158(1):169-79. PubMed ID: 8263022
[TBL] [Abstract][Full Text] [Related]
4. An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium.
Gotoh N; Perdue NR; Matsushima H; Sage EH; Yan Q; Clark JI
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4679-87. PubMed ID: 17898292
[TBL] [Abstract][Full Text] [Related]
5. Loss of insulin-like growth factor I receptor-dependent expression of p107 and cyclin A in cells that lack the extracellular matrix protein secreted protein acidic and rich in cysteine.
Basu A; Rodeck U; Prendergast GC; Howe CC
Cell Growth Differ; 1999 Nov; 10(11):721-8. PubMed ID: 10593648
[TBL] [Abstract][Full Text] [Related]
6. Effect of interleukin-10 on the gene expression of type I collagen, fibronectin, and decorin in human skin fibroblasts: differential regulation by transforming growth factor-beta and monocyte chemoattractant protein-1.
Yamamoto T; Eckes B; Krieg T
Biochem Biophys Res Commun; 2001 Feb; 281(1):200-5. PubMed ID: 11178980
[TBL] [Abstract][Full Text] [Related]
7. SPARC-thrombospondin-2-double-null mice exhibit enhanced cutaneous wound healing and increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges.
Puolakkainen PA; Bradshaw AD; Brekken RA; Reed MJ; Kyriakides T; Funk SE; Gooden MD; Vernon RB; Wight TN; Bornstein P; Sage EH
J Histochem Cytochem; 2005 May; 53(5):571-81. PubMed ID: 15872050
[TBL] [Abstract][Full Text] [Related]
8. Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis.
Puolakkainen PA; Brekken RA; Muneer S; Sage EH
Mol Cancer Res; 2004 Apr; 2(4):215-24. PubMed ID: 15140943
[TBL] [Abstract][Full Text] [Related]
9. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
Vuorio T; Kähäri VM; Black C; Vuorio E
J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
[TBL] [Abstract][Full Text] [Related]
10. Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor beta1 in cultured normal human fibroblasts.
Zhou X; Tan FK; Guo X; Wallis D; Milewicz DM; Xue S; Arnett FC
Arthritis Rheum; 2005 Jan; 52(1):257-61. PubMed ID: 15641096
[TBL] [Abstract][Full Text] [Related]
11. Absence of SPARC in lens epithelial cells results in altered adhesion and extracellular matrix production in vitro.
Weaver MS; Sage EH; Yan Q
J Cell Biochem; 2006 Feb; 97(2):423-32. PubMed ID: 16211577
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis.
Sangaletti S; Di Carlo E; Gariboldi S; Miotti S; Cappetti B; Parenza M; Rumio C; Brekken RA; Chiodoni C; Colombo MP
Cancer Res; 2008 Nov; 68(21):9050-9. PubMed ID: 18974151
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of soluble factors secreted by limbal fibroblasts.
Shimmura S; Miyashita H; Higa K; Yoshida S; Shimazaki J; Tsubota K
Mol Vis; 2006 May; 12():478-84. PubMed ID: 16710172
[TBL] [Abstract][Full Text] [Related]
14. Remodelling of cardiac extracellular matrix during beta-adrenergic stimulation: upregulation of SPARC in the myocardium of adult rats.
Masson S; Arosio B; Luvarà G; Gagliano N; Fiordaliso F; Santambrogio D; Vergani C; Latini R; Annoni G
J Mol Cell Cardiol; 1998 Aug; 30(8):1505-14. PubMed ID: 9737937
[TBL] [Abstract][Full Text] [Related]
15. Expression of transforming growth factor-beta and extracellular matrix by human peritoneal mesothelial cells and by fibroblasts from normal peritoneum and adhesions: effect of Tisseel.
Saed GM; Kruger M; Diamond MP
Wound Repair Regen; 2004; 12(5):557-64. PubMed ID: 15453838
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of various growth factors and cytokines on the syntheses of DNA, type I collagen, laminin, fibronectin, osteonectin/secreted protein, acidic and rich in cysteine (SPARC), and alkaline phosphatase by human pulp cells in culture.
Shiba H; Fujita T; Doi N; Nakamura S; Nakanishi K; Takemoto T; Hino T; Noshiro M; Kawamoto T; Kurihara H; Kato Y
J Cell Physiol; 1998 Feb; 174(2):194-205. PubMed ID: 9428806
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of extracellular proteins is correlated with angiogenesis in vitro.
Iruela-Arispe ML; Hasselaar P; Sage H
Lab Invest; 1991 Feb; 64(2):174-86. PubMed ID: 1705300
[TBL] [Abstract][Full Text] [Related]
18. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of the extracellular matrix protein SPARC in vSrc- and vJun-transformed chick embryo fibroblasts contributes to tumor formation in vivo.
Vial E; Castellazzi M
Oncogene; 2000 Mar; 19(14):1772-82. PubMed ID: 10777211
[TBL] [Abstract][Full Text] [Related]
20. Reduced excision repair cross-complementing 1 expression associates with enhanced papilloma formation and fibroblast transformation after genetic disruption of secreted protein acidic and rich in cysteine.
Kato Y; Tsukuda M; Nagashima Y; Koshika S; Sakai N; Yao M; Kubota Y; Aoki I; Colledge WH; Foidart JM; Hata R; Thompson EW
Int J Oncol; 2005 Sep; 27(3):759-68. PubMed ID: 16077926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
